- Published at
- by prnewswire.com
positive
positive
Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
/PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and...